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BRIEF COMMUNICATIONS: CLINICALLeft ventricular assist devices (LVADs) are now being im-
planted frequently as a bridge therapy to transplant or a desti-
nation therapy.1-3 Device technology is also changing in that
nonpulsatile axial flow pumps are being used as frequently as
pulsatile pumps at many centers. LVADs are effective in re-
storing circulation and unloading the left heart. LVAD sup-
port could result in a potential problem of right to left shunt
through the patent foramen ovale (PFO),4-8 and the practice
of performing transesophageal echocardiography (TEE)
looking for PFO at the time of surgery has been well estab-
lished.We describe an unusual case of significant hypoxemia
resulting from a defect in the interatrial septum (IAS) created
iatrogenically at the time of an electrophysiologic procedure
in a patient who subsequently underwent an axial flow pump
implantation.
CLINICAL SUMMARY
The patient was a 41-year-old man with advanced hyper-
trophic cardiomyopathy. He had a history of atrial fibrillation
and had undergone a transcatheter-based atrioventricular nodal
ablation procedure in the past. His condition continued to
deteriorate, and he had to be listed for heart transplantation
as status 1A supported on 2 inotrope. His echocardiogram
demonstrated severe concentric left ventricular hypertrophy
with a small ventricular cavity. An estimated left ejection frac-
tion was 35%, and he had a small noncompliant ventricle. He
was recommended to undergo LVAD implantation as a bridge
therapy to heart transplantation. Given the patient’s small left
ventricular cavity, the Jarvik-2000 axial pump (Jarvik Heart
Inc, NewYork, NY) was thought to be the best option for him.
Intraoperative TEE demonstrated a small hole in the IAS
with a left to right shunt (Figure 1, A). We inspected the atrial
septum to close this hole at the time of LVAD implantation.
No PFO was noted. There were multiple small holes that
were visible in the IAS, and the largest one that appeared to
be communicating to left atrium was closed primarily. How-
ever, a persistent shunting between the 2 atria was noted on
TEEafter thepatientwasweaned fromcardiopulmonarybypass
support. The shunt was now in the direction of right to left (Fig-
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axial flow pump support. Because we had failed to identify the
hole at the time of initial exploration of the IAS, we decided to
close the hole percutaneously via the transcatheter route. The
pump speed was reduced to 8000 from 11,000 rpm to maintain
as high arterial saturation as possible on 100% oxygen.
The patient was taken to the catheterization laboratory. In-
tracardiac echocardiography demonstrated a 3-mm hole in
the lower part of the IAS with a significant right to left shunt
(Figure 2, A). This defect was consistent with a puncture
hole usually created in the lower IAS with a catheter from
the inferior vena cava at the time of atrioventricular nodal
ablation. The Amplatzer (AGA Medical Corp, Golden Val-
ley, Minn) atrial septal defect closure device (6 mm) was in-
serted to close the shunt. A small residual right to left shunt
remained through the device itself (Figure 2, B). Arterial sat-
uration improved from 77% to a modest 90%. Nonetheless,
we brought the patient to the intensive care unit expecting
further improvement in the arterial saturation over time.
The small residual shunt within the Amplatzer device was
expected to close soon by forming clots over the mesh.
The patient also had significant intrapulmonary shunt based
on sampled pulmonary venous blood PO2 of 114 mm Hg on
100% oxygen before atrial septal defect closure. Arterial
saturation increased up to 96% within 1 hour. The patient’s
condition continued to improve. His FIO2 requirement de-
creased to 0.4 by the third day, and he was extubated on
the sixth day after LVAD insertion. A follow-up echocardi-
ography revealed no residual shunt through the IAS, and the
patient remains on the waiting list for heart transplantation.
DISCUSSION
There are several case reports of hypoxemia resulting
from right to left shunt through the IAS after LVAD implan-
tation.4-8 Reported cases of shunting usually involve PFO af-
ter implantation of pulsatile LVADs. At most centers,
performing a TEE study looking for intracardiac shunt
through a PFO has been a matter of routine practice.4,5
Our patient developed significant hypoxemia from the right
to left shunt through a 3-mm hole created iatrogenically at
the time of the electrophysiology procedure. An axial flow
pump may create a more significant right to left shunt than
a pulsatile pump because it unloads the heart continuously
and more effectively depending on the setting of the motor
speed. Even a small hole can result in clinically significant
hypoxemia with an axial flow pump.rgery c October 2008
Brief CommunicationsFIGURE 1. A, Intraoperative TEE showing a left to right shunt through the atrial septum before the LVAD implantation. B, Intraoperative TEE showing
a right to left shunt through the atrial septum after LVAD implantation.
FIGURE 2. A, Intracardiac echocardiogram showing a right to left shunt through the atrial septum. B, Intracardiac echocardiogram showing a tiny residual
shunt after atrial septal defect closure using the Amplatzer device (AGA Medical Corp, Golden Valley, Minn). RA, Right atrium; LA, left atrium.CONCLUSIONS
All intracardiac shunts should be closed at the time of sur-
gery for LVAD implantation. However, if hypoxemia from
an untreated intracardiac shunt develops in a patient, mea-
sures such as reducing airway pressure, inotropic support
of right heart function, and agents to reduce pulmonary vas-
cular resistance can be helpful as a temporizing measure.5,8
LVAD flow should be reduced to elevate left atrial pressure
while maintaining adequate tissue perfusion. Most impor-
tantly, the shunt needs to be closed promptly. A transcath-
eter-based percutaneous closure of an intracardiac shunt
can be an effective option.
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